Preventing and managing resistance in the clinical setting.
Kuritzkes
Daniel R
DR
Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA. dkuritzkes@partners.org
D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D024882:Drug Resistance, Viral / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D015497:HIV-1 / Q000235:genetics / Q000254:growth & development* / Q000276:immunology; D006801:Humans; D009154:Mutation; D010349:Patient Compliance; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D017211:Treatment Failure; D014779:Virus Replication / Q000276:immunology*
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors